Corewell Health
Locations
Transplant Summary
From January 1, 2022 to December 31st, 2023
Program type: Adult, Pediatric
14
Marrow
60
PBSC
3
Cord Blood
163
Autologous*
*PBSC or marrow
Overview
The Blood and Marrow Transplantation Program at Helen DeVos Children's Hospital takes a multidisciplinary approach to transplant. Our program works closely with the other specialties at Helen DeVos Children's Hospital to provide care for adults, children and their families.This center has been performing allogeneic transplants since 1998 and has been an NMDP transplant center since March 2002.
Attending physicians
Adult - Sami Brake, Rupin Shah
Pediatric - Ulrich Duffner, Troy QuiggTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
We have an on-site school liaison for pediatric patients. Corewell Health offers CAR-T cellular therapy for specific disease(s).Patient survival information for this center
Corewell Health
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 102 patients.The actual 1-year survival of these patients is 65.7%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.2% and 81.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.Corewell Health/Helen DeVos Children's Hospital
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 20 patients.The actual 1-year survival of these patients is 95%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 66.3% and 97.8%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
207
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC14Cord blood0Total15Unrelated donorMarrow1PBSC42Cord blood0Total43Total allogeneicMarrow2PBSC56Cord blood0Total58AutologousMarrowBoth marrow & PBSC 149PBSC—Cord blood—Total149Total combinedMarrowBoth marrow & PBSC 207PBSC—Cord blood0Total207Total pediatric transplants
33
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow6PBSC3Cord blood1Total10Unrelated donorMarrow6PBSC1Cord blood2Total9Total allogeneicMarrow12PBSC4Cord blood3Total19AutologousMarrowBoth marrow & PBSC 14PBSC—Cord blood—Total14Total combinedMarrowBoth marrow & PBSC 30PBSC—Cord blood3Total33All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18919-44545-64765+4Total25Unrelated 0-18919-441345-641865+12Total52Autologous 0-181419-442245-648165+46Total163Total 0-183219-444045-6410665+62Total240Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Financial representativeTiffany ChrismanPhone: (616) 486-7613NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Helen DeVos Children's Hospital - After Care and Transition (ACT) Clinic
100 Michigan St. NE Grand Rapids, MI 49503 Phone:616-391-9127 For more information about this program: https://www.spectrumhealth.org/services/cancer/supportive-integrative-and-palliative-care/survivorship-clinic (Opens in a new tab)Staff
Program Director:Ulrich Duffner, MDProgram Coordinator:Ulrich Duffner, MDMedical Specialties in Program
Allergy/immunology, cardiology, dermatology, endocrinology, gastroenterology, general surgery, hematology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Allogeneic transplant recipients
- 3 years after transplant.
- Patients who were transplanted as a child at this center up to age 22
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 22
- Will accept adult patients who were transplanted as a child at another center up to age 22